Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is testing adding gemcitabine to the standard Bacillus Calmette-Guérin therapy for people with recurrent non-muscle invasive bladder ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 3 | Status: RECRUITING